New!£32.83 with offer

Crystagen 20mg

£46.90

Crystagen is a synthetic tripeptide used as a research tool to investigate immune / lymphoid gene-expression regulation in experimental systems.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 98 % (HPLC, typical)
  • CAS Number: N/A
  • Molecular Formula: C14H21N3O8
Volume Pricing
Spend £50+Price £42.21
Spend £150+Price £37.52
Spend £500+Price £32.83

In stock

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Money Back Guarantee
Guaranteed Safe Checkout

secure payment bitcoin visa mastercard bitcoin tron crypto payment

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at 99%+ purity
  • Store frozen long term or in fridge when ready to be used
  • Sold for research purposes only
  • Contact us for Wholesale Orders

Download COA here: Crystagen_20mg.pdf
Please note: if you have a different Batch ID, please contact us for the latest COA.

Crystagen

Synonyms / Designations: Crystagen; Kristagen; EDP; immune / thymic peptide bioregulator (a defined short-peptide component of Thymalin)
Amino Acid Sequence: Glu-Asp-Pro (EDP)
CAS Number: N/A
Molecular Formula: C14H21N3O8
Molecular Weight: 359.34 g/mol
Purity: ≥ 99 % (HPLC)
Appearance: White to off-white lyophilised powder
Pack Size: 20 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C or below
Solubility: Soluble in water and buffered aqueous solutions

Description & Mechanism

Crystagen is a short synthetic tripeptide (EDP), identified as one of the bioactive short peptides within the thymic preparation Thymalin, used as a molecular probe for studying immune / lymphoid gene regulation in experimental systems. In cellular models it is studied for effects on lymphocyte proliferation and T-cell-associated markers (e.g. CD3+, CD4+ populations and the CD4+/CD8+ ratio).

Consistent with the Khavinson model, EDP is studied as a cell-penetrating peptide that may bind double-stranded DNA and/or histones to influence expression of immune-system genes. It functions in the laboratory as a research probe for short-peptide / chromatin interaction and immune gene-expression studies; observed effects depend on concentration, model system and exposure conditions.

Applications in Research

  • In-vitro lymphocyte proliferation and T-cell marker assays (CD3+/CD4+, CD4+/CD8+)
  • Cellular models of immune / thymic gene regulation and immunosenescence
  • Studies of EDP as a defined active component of the Thymalin peptide complex
  • Probe for short-peptide DNA/histone-binding studies

Specifications Summary

ParameterTypical Value / Range
Purity (HPLC)≥ 99 %
AppearanceWhite to off-white lyophilised powder
Molecular Weight359.34 g/mol
Peptide TypeSynthetic linear tripeptide bioregulator (Khavinson cytogen family; thymic/immune)
SolubilityWater, buffered aqueous solutions
Storage–20 °C, desiccated, dark
Pack Size20 mg (total)

Handling, Reconstitution & Stability

  • Weigh under dry conditions; peptide is hygroscopic
  • Reconstitute in sterile water or appropriate buffered aqueous solution depending on assay requirements
  • Avoid vigorous agitation during dissolution
  • Filter sterilize if required (e.g. 0.22 µm) prior to use
  • Aliquot and store reconstituted solutions at –20 °C or below to minimise degradation
  • Avoid repeated freeze–thaw cycles

Precautions & Notes

  • Experimental behaviour is dependent on concentration, model system and exposure conditions
  • As an immunomodulatory research peptide, appropriate experimental controls are recommended
  • Prolonged exposure to light, elevated temperature or aqueous environments may reduce stability
  • Intended strictly for laboratory research use; not for human or veterinary application

References

Khavinson VKh, Kuznik BI, et al. The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity. Biol Bull Rev. 2021. (PMC8365293)
https://pmc.ncbi.nlm.nih.gov/articles/PMC8365293/

Khavinson VKh, et al. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients. (PMC8654498)
https://pmc.ncbi.nlm.nih.gov/articles/PMC8654498/

Khavinson VKh, Linkova NS, et al. Short cell-penetrating peptides: a model of interactions with gene promoter sites.
https://pubmed.ncbi.nlm.nih.gov/23484211/

Khavinson VKh, Popovich IG, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053.
https://www.mdpi.com/1420-3049/26/22/7053

Keywords: Crystagen, EDP, immune peptide bioregulator, synthetic tripeptide